On Tuesday, Zealand Pharma secured a USD 50m option for potential acquisitions of products or companies in a financing agreement with private investment firm Oberland Capital.
However, with clinical trials underway and its goal of having five products on the market in 2025, Zealand Pharma is already well-armed in this business area, CEO at Zealand Pharma Emmanuel Dulac tells MedWatch. Funding from the option, which much be exercised before June 30, 2023, would likely be spent elsewhere.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Genmab to submit cancer candidate epcoritamab to the FDA before year-end
The US Food and Drug Administration will receive a marketing authorization application from Genmab and its partner Abbvie in the second half of this year.
Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
Bavarian Nordic’s smallpox vaccine Imvanex has previously been used off-label to protect close contacts from monkeypox in several countries. The Danish vaccine firm is now working with the EMA to expand the label in an ”accelerated process.”
Leo Pharma eczema treatment recommended in two UK countries
After postponing the decision in April, the British medicines council NICE has now ruled that Adtralza can be recommended to treat atopic dermatitis.
Fujifilm invests USD 1.5bn in Danish factory
Japanese firm Fujifilm Diosynth Biotechnologies is investing DKK 11bn (USD 1.5bn) in its factor in Northern Zealand, Denmark. The expansion will provide 450 jobs.
Life science firms are planning USD 6.3bn construction spree in Denmark
Fujifilm’s expansion to its factory in Hillerød means that the life science sector has announced DKK 12bn (USD 1.7bn) in facility investments in Denmark since May.
QA Specialist for Product Equipment Qualification 
Specialist within Project Management and Launch, Regulatory Affairs Life Cycle Management 
Global Product Manager - Pulmonology 
Senior Toxicologist 
KLIFO is looking for a Project Director for our office in Denmark or Germany or Sweden 
(Sr) Clinical Trial Manager 
Principal Laboratory Technologist Medicinal Chemistry 
Device Associate Director/Senior Project Leader 
Director Regulatory Affairs 
Project Managers keep all of us healthy